Formulation Design of Ranitidine Hydrochloride To Reduce its Moisture Absorption Characteristics

References

1. 1.↵
   1. Hirai N.,
   2. Ishikawa K.,
   3. Takahashi K.

   Improvement of the agitation granulation method to prepare granules containing a high content of a very hygroscopic drug. J. Pharm. Pharmacol. 2006, 58, 1437– 1441.

   OpenUrlPubMed
2. 2.↵
   1. Huang Y. T.,
   2. Tsai T. R.,
   3. Cheng C. J.,
   4. Cham T. M.,
   5. Lai T. F.,
   6. Chuo W. H.

   Formulation design of a highly hygroscopic drug (pyridostigmine bromide) for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties. Drug Dev. Ind. Pharm. 2007, 33 ( 4), 403– 416.

   OpenUrlPubMed
3. 3.↵
   1. Crookes D. L.

   Process for Forming Form 2 Ranitidine Hydrochloride. U.S. Patent 4,672,133, 1987.
4. 4.↵
   1. Fischer W.,
   2. Klokkers K.

   Crystalline Cyclodextrin Complexes of Ranitidine Hydrochloride, Process for their Preparation and Pharmaceutical Compositions Containing the Same. U.S. Patent 5,665,767, 1997.
5. 5.↵
   1. Atyabi F.,
   2. Koochak M.,
   3. Dinarvand R.

   The effect of loading solution and dissolution media on release of diclofenac from ion exchange resins. DARU 2002, 10( 1), 17– 22.

   OpenUrl
6. 6.↵
   1. Hughes L.,
   2. Khanna S.

   Dosage Form of Hygroscopic Active Ingredient. European Patent 1346732, 2003.
7. 7.↵
   1. Visalakshi N. A.,
   2. Marriappan T. T.,
   3. Bhutani H.,
   4. Singh S.

   Behavior of moisture gain and equilibrium moisture content (EMC) of various drug substances and correlation with compendial information on hygroscopicity and loss on drying. Pharm. Dev. Technol. 2005, 10 ( 4), 489– 497.

   OpenUrlPubMed
8. 8.↵
   1. Kaur H.,
   2. Mariappan T. T,
   3. Singh S.

   Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. Part III: Various drug substances and excipients. Pharm. Technol. 2003, 27( 12), 52– 56.

   OpenUrl
9. 9.↵
   United States Pharmacopoeia 25, Asian Edition; United States Pharmacopoeial Convention, Inc.: Rockville, MD, 2002; p 2592.
10. 10.↵
    1. Dabhade H. M.,
    2. Attarde P. U.

    Rapidly Dispersing/Disintegrating Composition. U.S. Patent Application 20070036852, 2007.
11. 11.↵
    1. Teraoka P.,
    2. Otsuka M.,
    3. Matsuda Y.

    Effects of temperature and relative humidity on solid state chemical stability of ranitidine hydrochloride. J. Pharm. Sci. 1993, 82 ( 6), 601– 604.

    OpenUrlCrossRefPubMed